Parallax Volatility Advisers
CYTK icon

Parallax Volatility Advisers’s Cytokinetics CYTK Stock Holding History

Parallax Volatility Advisers’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,039
Closed -$193K – 1550
2025
Q4 		$193K Buy
3,039
+130
+4% +$8.09K ﹤0.01% 1389
2025
Q3 		$160K Sell
2,909
-1,980
-40% -$81.6K ﹤0.01% 1388
2025
Q2 		$162K Sell
4,889
-33,673
-87% -$1.17M ﹤0.01% 1352
2025
Q1 		$1.55M Sell
38,562
-4,221
-10% -$194K ﹤0.01% 938
2024
Q4 		$2.01M Buy
42,783
+4,323
+11% +$225K ﹤0.01% 1128
2024
Q3 		$2.03M Buy
38,460
+7,041
+22% +$392K ﹤0.01% 1124
2024
Q2 		$1.7M Buy
31,419
+30,150
+2,376% +$1.82M ﹤0.01% 1092
2024
Q1 		$89K Buy
+1,269
New +$98.1K ﹤0.01% 1609
2023
Q1 		– Sell
-427
Closed -$19.6K – 2806
2022
Q4 		$19.6K Buy
427
+24
+6% +$1.03K ﹤0.01% 2487
2022
Q3 		$20K Buy
+403
New +$19.4K ﹤0.01% 2745
2021
Q2 		– Sell
-273
Closed -$6K – 3100
2021
Q1 		$6K Buy
+273
New +$5.83K ﹤0.01% 3135
2020
Q4 		– Sell
-7,228
Closed -$156K – 3330
2020
Q3 		$156K Buy
+7,228
New +$169K ﹤0.01% 2609
2018
Q1 		– Sell
-6,342
Closed -$52K – 2555
2017
Q4 		$52K Buy
+6,342
New +$72K ﹤0.01% 3208

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parallax Volatility Advisers's CYTK Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 3,039 shares — an estimated $193K sold.

Parallax Volatility Advisers first reported a position in CYTK in Q4 2017 and held it in 13 quarters. The position peaked at $2.03M in Q3 2024. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 3,039 Cytokinetics shares in Q1 2026, an estimated $193K.
  • Parallax Volatility Advisers first reported a position in Cytokinetics in Q4 2017 and held it in 13 quarters.
  • Parallax Volatility Advisers's Cytokinetics position peaked at $2.03M in Q3 2024.
  • 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.